Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1816 AL 1830

Mild cognitive impairment in Parkinson's disease: a distinct clinical entity?

Wen MC, Chan LL, Tan LCS, Tan EK.

Transl Neurodegener. 2017 Sep 13;6:24. doi: 10.1186/s40035-017-0094-4. eCollection 2017.

Falling upward with Parkinson's disease

Buetow SA, Martínez-Martín P, McCormack B.

NPJ Parkinsons Dis. 2017 Sep 13;3:29. doi: 10.1038/s41531-017-0031-3. eCollection 2017.

Comparison of General and Local Anesthesia for Deep Brain Stimulator Insertion: A Systematic Review

Sheshadri V, Rowland NC, Mehta J, Englesakis M, Manninen P, Venkatraghavan L.

Can J Neurol Sci. 2017 Nov;44(6):697-704. doi: 10.1017/cjn.2017.224. Epub 2017 Sep 18.

A Critical Assessment of Exosomes in the Pathogenesis and Stratification of Parkinson's Disease

Tofaris GK.

J Parkinsons Dis. 2017;7(4):569-576. doi: 10.3233/JPD-171176.

Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient

Friedman J, Yeboah E, Hermenau M.

Clin Neuropharmacol. 2017 Sep/Oct;40(5):233-234. doi: 10.1097/WNF.0000000000000230.

Baicalein as a potent neuroprotective agent: A review

Sowndhararajan K, Deepa P, Kim M, Park SJ, Kim S.

Biomed Pharmacother. 2017 Nov;95:1021-1032. doi: 10.1016/j.biopha.2017.08.135. Epub 2017 Sep 13.

Fundamental limit of alpha-synuclein pathology in gastrointestinal biopsy as a pathologic biomarker of Parkinson's disease: Comparison with surgical specimens

Shin C, Park SH, Yun JY, Shin JH, Yang HK, Lee HJ, Kong SH, Suh YS, Shen G, Kim Y, Kim HJ, Jeon B.

Parkinsonism Relat Disord. 2017 Nov;44:73-78. doi: 10.1016/j.parkreldis.2017.09.001. Epub 2017 Sep 4.

Insights into the structural biology of Gaucher disease

Smith L, Mullin S, Schapira AHV.

Exp Neurol. 2017 Dec;298(Pt B):180-190. doi: 10.1016/j.expneurol.2017.09.010. Epub 2017 Sep 18.

Essential tremor & Parkinson disease: Recognizing the differences

Vernon GM, Leiningen C, Thomas CA, Dunlop SR.

Nurse Pract. 2017 Oct 18;42(10):35-40. doi: 10.1097/01.NPR.0000524667.01599.d0.

Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease

Jeong S.

Mol Cells. 2017 Sep 30;40(9):613-620. doi: 10.14348/molcells.2017.0096. Epub 2017 Sep 20.

A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson's disease

Guin D, Mishra MK, Talwar P, Rawat C, Kushwaha SS, Kukreti S, Kukreti R.

BMC Med Genomics. 2017 Sep 19;10(1):56. doi: 10.1186/s12920-017-0291-0.

Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders

Salvadores N, Sanhueza M, Manque P, Court FA.

Front Neurosci. 2017 Sep 4;11:451. doi: 10.3389/fnins.2017.00451. eCollection 2017.

Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies

Weil RS, Lashley TL, Bras J, Schrag AE, Schott JM.

F1000Res. 2017 Aug 30;6:1604. doi: 10.12688/f1000research.11725.1. eCollection 2017.

Spinal Arteriolosclerosis Is Common in Older Adults and Associated With Parkinsonism

Buchman AS, Leurgans SE, Nag S, VanderHorst VGJM, Kapasi A, Schneider JA, Bennett DA.

Stroke. 2017 Oct;48(10):2792-2798. doi: 10.1161/STROKEAHA.117.017643. Epub 2017 Sep 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias